# Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1

> **NCT01925482** · PHASE1 · COMPLETED · sponsor: **Cuneyt M. Alper** · enrollment: 16 (actual)

## Conditions studied

- Middle Ear Gas Exchange

## Interventions

- **DRUG:** 6%CO2, 25%O2, balance N2
- **DRUG:** 6% CO2, 0%O2, balance N2
- **DRUG:** 20%CO2, 6%O2, balance N2
- **DRUG:** 0%CO2, 6%O2, balance N2
- **DRUG:** 6% CO2, 6%O2, balance N2
- **DRUG:** 6%CO2, 6%O2, 0%N2, balance argon

## Key facts

- **NCT ID:** NCT01925482
- **Lead sponsor:** Cuneyt M. Alper
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-13
- **Primary completion:** 2015-04-24
- **Final completion:** 2015-05-19
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925482, "Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01925482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*